A short, evidence-grounded conversation about Cyt c oxidase and its place in longevity science.
Speaker 1
...so it's this fundamental molecular relationship. Red and near-infrared light specifically targets and energizes cytochrome c oxidase, often abbreviated as CCO.
Speaker 2
And CCO is a key player in the mitochondrial energy pathway, right? It's essential for cellular respiration and ATP production. So, more energized CCO means more ATP output. That’s a pretty direct mechanism.
Speaker 1
Exactly. That's the core hypothesis explaining many of the observed benefits of photobiomodulation, or PBM. We see a significant boost in ATP, which is cellular energy, when CCO is activated this way. This has been shown in studies, for instance, a review in Photomedicine and Laser Surgery in 2017.
Speaker 2
But what are the open questions here? What’s still genuinely unknown or unproven, even with that clear molecular pathway?
Speaker 1
Well, we know the mechanism of CCO activation by light is well-established in vitro and in vivo. But the optimal dosing for various tissues and conditions, especially for systemic effects, is still being mapped out. How much light, at what wavelength, for how long, to achieve specific outcomes across different parts of the body? That’s still very much an active area of research.
Speaker 2
So, we understand how it works at the cellular level, but the practical application and optimization for humans is where the unknowns lie.
Speaker 1
Precisely. And also, the long-term effects and safety profile of consistent, widespread PBM use across a healthy population. Most studies are shorter term or focused on specific conditions. What happens after years of regular use? That’s still largely unproven.
Educational research discussion only — not medical advice. Statements have not been
evaluated by the FDA. Nothing here is intended to diagnose, treat, cure or prevent any disease.
Talk to a qualified clinician before changing any treatment.